Transcriptional modulation of pattern recognition receptors in acute colitis in mice

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 12, 2013, Pages 2162-2172

  Zheng, Bin ^a   Morgan, Mary E ^a   van de Kant, Hendrik J G ^a   Garssen, Johan ^a,b   Folkerts, Gert ^a   Kraneveld, Aletta D ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b DANONE RESEARCH   (Netherlands)

Author keywords

Inflammatory bowel disease; NOD; Th1 cells; Th17 cells; TLR

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; GAMMA INTERFERON; INTERLEUKIN 17; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECUM; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL;

EID: 84883721491     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.07.004     Document Type: Article

References (65)

1. Lakatos P.L. Recent trends in the epidemiology of inflammatory bowel diseases: up or down?. World J. Gastroenterol. 2006, 12:6102-6108.
2. Brown S.J., Mayer L. The immune response in inflammatory bowel disease. Am. J. Gastroenterol. 2007, 102:2058-2069.
3. Walsh D., McCarthy J., O'Driscoll C., Melgar S. Pattern recognition receptors-molecular orchestrators of inflammation in inflammatory bowel disease. Cytokine Growth Factor Rev. 2012, 24:91-104.
4. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
5. Takeda K., Takeuchi O., Akira S. Recognition of lipopeptides by Toll-like receptors. J. Endotoxin Res. 2002, 8:459-463.
6. Rivas M.A., Beaudoin M., Gardet A., Stevens C., Sharma Y., Zhang C.K., Boucher G., Ripke S., Ellinghaus D., Burtt N., Fennell T., Kirby A., Latiano A., Goyette P., Green T., Halfvarson J., Haritunians T., Korn J.M., Kuruvilla F., Lagace C., Neale B., Lo K.S., Schumm P., Torkvist L., Dubinsky M.C., Brant S.R., Silverberg M.S., Duerr R.H., Altshuler D., Gabriel S., Lettre G., Franke A., D'Amato M., McGovern D.P., Cho J.H., Rioux J.D., Xavier R.J., Daly M.J. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat. Genet. 2011, 43:1066-1073.
7. Cario E. Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut 2005, 54:1182-1193.
8. Brain O., Allan P., Simmons A. NOD2-mediated autophagy and Crohn disease. Autophagy 2010, 6:412-414.
9. Pierik M., Joossens S., Van Steen K., Van Schuerbeek N., Vlietinck R., Rutgeerts P., Vermeire S. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm. Bowel Dis. 2006, 12:1-8.
10. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., Frees K., Watt J.L., Schwartz D.A. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 2000, 25:187-191.
11. Szebeni B., Veres G., Dezsofi A., Rusai K., Vannay A., Mraz M., Majorova E., Arato A. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease. Clin. Exp. Immunol. 2008, 151:34-41.
12. Cario E., Podolsky D.K. Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 2000, 68:7010-7017.
13. Steenholdt C., Andresen L., Pedersen G., Hansen A., Brynskov J. Expression and function of Toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel disease. Scand. J. Gastroenterol. 2009, 44:195-204.
14. Melgar S., Karlsson L., Rehnstrom E., Karlsson A., Utkovic H., Jansson L., Michaelsson E. Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease. Int. Immunopharmacol. 2008, 8:836-844.
15. Gottfries J., Melgar S., Michaelsson E. Modelling of mouse experimental colitis by global property screens: a holistic approach to assess drug effects in inflammatory bowel disease. PLoS One 2012, 7:e30005.
16. te Velde A.A., de Kort F., Sterrenburg E., Pronk I., ten Kate F.J., Hommes D.W., van Deventer S.J. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflamm. Bowel Dis. 2007, 13:325-330.
17. Egger B., Bajaj-Elliott M., MacDonald T.T., Inglin R., Eysselein V.E., Buchler M.W. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 2000, 62:240-248.
18. Plevy S.E., Landers C.J., Prehn J., Carramanzana N.M., Deem R.L., Shealy D., Targan S.R. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J. Immunol. 1997, 159:6276-6282.
19. Parronchi P., Romagnani P., Annunziato F., Sampognaro S., Becchio A., Giannarini L., Maggi E., Pupilli C., Tonelli F., Romagnani S. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am. J. Pathol. 1997, 150:823-832.
20. Alex P., Zachos N.C., Nguyen T., Gonzales L., Chen T.E., Conklin L.S., Centola M., Li X. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm. Bowel Dis. 2009, 15:341-352.
21. Fukata M., Michelsen K.S., Eri R., Thomas L.S., Hu B., Lukasek K., Nast C.C., Lechago J., Xu R., Naiki Y., Soliman A., Arditi M., Abreu M.T. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288:G1055-G1065.
22. Rakoff-Nahoum S., Paglino J., Eslami-Varzaneh F., Edberg S., Medzhitov R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
23. Cario E., Gerken G., Podolsky D.K. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 2007, 132:1359-1374.
24. Obermeier F., Dunger N., Strauch U.G., Hofmann C., Bleich A., Grunwald N., Hedrich H.J., Aschenbrenner E., Schlegelberger B., Rogler G., Scholmerich J., Falk W. CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation. Gastroenterology 2005, 129:913-927.
25. Vijay-Kumar M., Wu H., Aitken J., Kolachala V.L., Neish A.S., Sitaraman S.V., Gewirtz A.T. Activation of Toll-like receptor 3 protects against DSS-induced acute colitis. Inflamm. Bowel Dis. 2007, 13:856-864.
26. Rachmilewitz D., Katakura K., Karmeli F., Hayashi T., Reinus C., Rudensky B., Akira S., Takeda K., Lee J., Takabayashi K., Raz E. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004, 126:520-528.
27. Rhee S.H., Im E., Riegler M., Kokkotou E., O'Brien M., Pothoulakis C. Pathophysiological role of toll-like receptor 5 engagement by bacterial flagellin in colonic inflammation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13610-13615.
28. Vijay-Kumar M., Aitken J.D., Sanders C.J., Frias A., Sloane V.M., Xu J., Neish A.S., Rojas M., Gewirtz A.T. Flagellin treatment protects against chemicals, bacteria, viruses, and radiation. J. Immunol. 2008, 180:8280-8285.
29. Farhat K., Riekenberg S., Heine H., Debarry J., Lang R., Mages J., Buwitt-Beckmann U., Roschmann K., Jung G., Wiesmuller K.H., Ulmer A.J. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J. Leukoc. Biol. 2008, 83:692-701.
30. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
31. Diebold S.S., Kaisho T., Hemmi H., Akira S., Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
32. Heil F., Ahmad-Nejad P., Hemmi H., Hochrein H., Ampenberger F., Gellert T., Dietrich H., Lipford G., Takeda K., Akira S., Wagner H., Bauer S. The toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur. J. Immunol. 2003, 33:2987-2997.
33. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., Bamba T., Fujiyama Y. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003, 52:65-70.
34. Rajeevan M.S., Ranamukhaarachchi D.G., Vernon S.D., Unger E.R. Use of real-time quantitative PCR to validate the results of cDNA array and differential display PCR technologies. Methods 2001, 25:443-451.
35. Tomita T., Kanai T., Fujii T., Nemoto Y., Okamoto R., Tsuchiya K., Totsuka T., Sakamoto N., Akira S., Watanabe M. MyD88-dependent pathway in T cells directly modulates the expansion of colitogenic CD4+ T cells in chronic colitis. J. Immunol. 2008, 180:5291-5299.
36. Hart A.L., Al-Hassi H.O., Rigby R.J., Bell S.J., Emmanuel A.V., Knight S.C., Kamm M.A., Stagg A.J. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 2005, 129:50-65.
37. Buwitt-Beckmann U., Heine H., Wiesmuller K.H., Jung G., Brock R., Akira S., Ulmer A.J. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J. Biol. Chem. 2006, 281:9049-9057.
38. Netea M.G., van de Veerdonk F., Verschueren I., van der Meer J.W., Kullberg B.J. Role of TLR1 and TLR6 in the host defense against disseminated candidiasis. FEMS Immunol. Med. Microbiol. 2008, 52:118-123.
39. Fong D.J., Hogaboam C.M., Matsuno Y., Akira S., Uematsu S., Joshi A.D. Toll-like receptor 6 drives interleukin-17A expression during experimental hypersensitivity pneumonitis. Immunology 2010, 130:125-136.
40. Kathrani A., House A., Catchpole B., Murphy A., German A., Werling D., Allenspach K. Polymorphisms in the TLR4 and TLR5 gene are significantly associated with inflammatory bowel disease in German shepherd dogs. PLoS One 2010, 5:e15740.
41. Wang Y., Devkota S., Musch M.W., Jabri B., Nagler C., Antonopoulos D.A., Chervonsky A., Chang E.B. Regional mucosa-associated microbiota determine physiological expression of TLR2 and TLR4 in murine colon. PLoS One 2010, 5:e13607.
42. Cavassani K.A., Ishii M., Wen H., Schaller M.A., Lincoln P.M., Lukacs N.W., Hogaboam C.M., Kunkel S.L. TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events. J. Exp. Med. 2008, 205:2609-2621.
43. Kariko K., Ni H., Capodici J., Lamphier M., Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J. Biol. Chem. 2004, 279:12542-12550.
44. Lim D.M., Wang M.L. Toll-like receptor 3 signaling enables human esophageal epithelial cells to sense endogenous danger signals released by necrotic cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301:G91-G99.
45. Noble C.L., Abbas A.R., Cornelius J., Lees C.W., Ho G.T., Toy K., Modrusan Z., Pal N., Zhong F., Chalasani S., Clark H., Arnott I.D., Penman I.D., Satsangi J., Diehl L. Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut 2008, 57:1398-1405.
46. Noble C.L., Abbas A.R., Lees C.W., Cornelius J., Toy K., Modrusan Z., Clark H.F., Arnott I.D., Penman I.D., Satsangi J., Diehl L. Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis. Inflamm. Bowel Dis. 2010, 16:1717-1728.
47. Ortega-Cava C.F., Ishihara S., Rumi M.A., Aziz M.M., Kazumori H., Yuki T., Mishima Y., Moriyama I., Kadota C., Oshima N., Amano Y., Kadowaki Y., Ishimura N., Kinoshita Y. Epithelial Toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis. Clin. Vaccine Immunol. 2006, 13:132-138.
48. Stanislawowski M., Wierzbicki P.M., Golab A., Adrych K., Kartanowicz D., Wypych J., Godlewski J., Smoczynski M., Kmiec Z. Decreased Toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients. J. Physiol. Pharmacol. 2009, 60(Suppl. 4):71-75.
49. Gewirtz A.T., Navas T.A., Lyons S., Godowski P.J., Madara J.L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 2001, 167:1882-1885.
50. Vijay-Kumar M., Sanders C.J., Taylor R.T., Kumar A., Aitken J.D., Sitaraman S.V., Neish A.S., Uematsu S., Akira S., Williams I.R., Gewirtz A.T. Deletion of TLR5 results in spontaneous colitis in mice. J. Clin. Invest. 2007, 117:3909-3921.
51. Oliveira A.C., Peixoto J.R., de Arruda L.B., Campos M.A., Gazzinelli R.T., Golenbock D.T., Akira S., Previato J.O., Mendonca-Previato L., Nobrega A., Bellio M. Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J. Immunol. 2004, 173:5688-5696.
52. Sanjuan M.A., Dillon C.P., Tait S.W., Moshiach S., Dorsey F., Connell S., Komatsu M., Tanaka K., Cleveland J.L., Withoff S., Green D.R. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 2007, 450:1253-1257.
53. Hoarau C., Lagaraine C., Martin L., Velge-Roussel F., Lebranchu Y. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J. Allergy Clin. Immunol. 2006, 117:696-702.
54. Sainathan S.K., Bishnupuri K.S., Aden K., Luo Q., Houchen C.W., Anant S., Dieckgraefe B.K. Toll-like receptor-7 ligand Imiquimod induces type I interferon and antimicrobial peptides to ameliorate dextran sodium sulfate-induced acute colitis. Inflamm. Bowel Dis. 2012, 18:955-967.
55. Bleich A., Janus L.M., Smoczek A., Westendorf A.M., Strauch U., Mähler M., Hedrich H.J., Fichtner-Feigl S., Schölmerich J., Falk W., Hofmann C., Obermeier F. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction. Gastroenterology 2009, 136:278-287.
56. Katakura K., Lee J., Rachmilewitz D., Li G., Eckmann L., Raz E. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J. Clin. Invest. 2005, 115:695-702.
57. Fitzgerald-Bocarsly P., Dai J., Singh S. Plasmacytoid dendritic cells and type I IFN: 50years of convergent history. Cytokine Growth Factor Rev. 2008, 19:3-19.
58. Johansson M.E.V., Gustafsson J.K., Sjöberg K.E., Petersson J., Holm L., Sjövall H., Hansson G.C. Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model. PLoS One 2010, 5:e12238.
59. Melgar S., Karlsson A., Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288:G1328-G1338.
60. Zhou L., Lopes J.E., Chong M.M., Ivanov I.I., Min R., Victora G.D., Shen Y., Du J., Rubtsov Y.P., Rudensky A.Y., Ziegler S.F., Littman D.R. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008, 453:236-240.
61. Lei J., Hasegawa H., Matsumoto T., Yasukawa M. Peroxisome proliferator-activated receptor alpha and gamma agonists together with TGF-beta convert human CD4+CD25- T cells into functional Foxp3+ regulatory T cells. J. Immunol. 2010, 185:7186-7198.
62. Klotz L., Burgdorf S., Dani I., Saijo K., Flossdorf J., Hucke S., Alferink J., Nowak N., Beyer M., Mayer G., Langhans B., Klockgether T., Waisman A., Eberl G., Schultze J., Famulok M., Kolanus W., Glass C., Kurts C., Knolle P.A. The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J. Exp. Med. 2009, 206:2079-2089.
63. Dubuquoy L., Jansson E.A., Deeb S., Rakotobe S., Karoui M., Colombel J.F., Auwerx J., Pettersson S., Desreumaux P. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 2003, 124:1265-1276.
64. Eun C.S., Han D.S., Lee S.H., Paik C.H., Chung Y.W., Lee J., Hahm J.S. Attenuation of colonic inflammation by PPARgamma in intestinal epithelial cells: effect on Toll-like receptor pathway. Dig. Dis. Sci. 2006, 51:693-697.
65. De Luca A., Montagnoli C., Zelante T., Bonifazi P., Bozza S., Moretti S., D'Angelo C., Vacca C., Boon L., Bistoni F., Puccetti P., Fallarino F., Romani L. Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J. Immunol. 2007, 179:5999-6008.